Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros








Intervalo de año
1.
Chinese Pediatric Emergency Medicine ; (12): 405-407, 2012.
Artículo en Chino | WPRIM | ID: wpr-427190

RESUMEN

Objective To explore the method that can block the infection route from stomach to lung so as to reduce the incidence of ventilator-associated pneumonia (VAP) in neonates.Methods Neonates with mechanical ventilation were randomly divided into two groups,the treatment group(40 cases) were given probiotics (Bifidobacteria) by nasogastric feeding,control group(40 cases) were given nothing.Prospective survey was performed on the incidence of VAP,gastric juice pH,gastric bacterial colonization,the homology between gastric bacterial colonization and VAP pathogen.Results The VAP incidence of treatment group and control group was 12.5% (5/40) and 47.5% (19/40) respectively,there was significant difference between the two groups ( x2 =10.21,P < 0.01 ).The onset time of VAP in treatment group [ ( 5.4 ±2.1 ) d] was later than that of control group[ (4.3 ± 1.0) d] ( t =3.2,P <0.01 ).The ratio of treatment group that gastric juice dropped to pH≤3 (80.0%,32/40) was higher than that of control group(47.5%,19/40) ( x2 =11.5,P < 0.01 ) ; and the ratio of gastric bacterial colonization in treatment group ( 30.0%,12/40) was lower than that in control group(80.0%,32/40) ( x2 =16.9,P <0.01 ).The homology ratio between VAP pathogen and colonization bacteria in treatment group (40.0%,2/5 ) was lower than that in control group (78.9 %,15/19 ) ( x2 =8.7,P < 0.01 ).Conclusion Probiotics can reduce gastric juice pH of neonates and inhibit gastric bacterial colonization.The onset time of VAP can be delayed,the incidence of VAP can be reduced effectively.

2.
Korean Journal of Blood Transfusion ; : 210-216, 2012.
Artículo en Coreano | WPRIM | ID: wpr-127533

RESUMEN

BACKGROUND: Genetic variants of virus appear to differ depending on the country, race, infection route, and so on. To characterize the main HIV subtype in infected blood donors and inquire about the route of HIV infection, we analyzed HIV subtype for samples that showed reactive results on the anti-HIV 1/2 and HIV-1 NAT test from September 2007 to February 2010. METHODS: To identify the HIV-1 subtype of the 90 samples that showed reactive results on the anti-HIV test and HIV-1 NAT, we performed HIV 1/2 Western blot assay, HIV RNA quantitative assay, HIV-1 nested PCR, and HIV-1 RNA sequencing. RESULTS: A total of 85 samples (94.4%) were confirmed to be HIV-1 subtypes. Among them, 82 samples (96.5%) were subtype B; and subtype A, C, and G was confirmed for one case each (1.2% for each case). We could not identify the subtype of the other five samples. One of them was amplified by nested PCR, but was not confirmed of the subtype, and four samples were not amplified even by nested PCR. CONCLUSION: The main HIV-1 subtype among the HIV-infected blood donors was confirmed to be subtype B. In addition, we identified one case each of HIV-1 subtype A, C, and G, which was not detected in blood donors in the past. It appeared that the route of HIV infection in Korea had become complicated. Therefore, we concluded that continuous research for HIV subtype analysis and efficient management of blood donors is needed.


Asunto(s)
Humanos , Donantes de Sangre , Western Blotting , Grupos Raciales , VIH , Infecciones por VIH , VIH-1 , Corea (Geográfico) , Reacción en Cadena de la Polimerasa , ARN , Ácidos Urónicos , Virus
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA